Translocation Biosensors – Cellular System Integrators to Dissect CRM1-Dependent Nuclear Export by Chemicogenomics
Open Access
Abstract
Fluorescent protein biosensors are powerful cellular systems biology tools for dissecting the complexity of cellular processes with high spatial and temporal resolution. As regulated nucleo-cytoplasmic transport is crucial for the modulation of numerous (patho)physiological cellular responses, a detailed understanding of its molecular mechanism would open up novel options for a rational manipulation of the cell. In contrast to genetic approaches, we here established and employed high-content cellular translocation biosensors applicable for dissecting nuclear export by chemicogenomics. A431 cell lines, stably expressing a translocation biosensor composed of glutathione S-transferase, GFP and a rational combination of nuclear import and export signals, were engineered by antibiotic selection and flow cytometry sorting. Using an optimized nuclear translocation algorithm, the translocation response could be robustly quantified on the Cellomics Arrayscan® VTI platform. Subsequent to assay optimization, the assay was developed into a higher density 384-well format high-content assay and employed for the screening of the 17K ChemBioNet compound collection. This library was selected on the basis of a genetic algorithm used to identify maximum common chemical substructures in a database of annotated bioactive molecules and hence, is well-placed in the chemical space covered by bioactive compounds. Automated multiparameter data analysis combined with visual inspection allowed us to identify and to rationally discriminate true export inhibitors from false positives, which included fluorescent compounds or cytotoxic substances that dramatically affected the cellular morphology. A total of 120 potential hit compounds were selected for Cellomics Arrayscan® VTI based rescreening. The export inhibitory activity of 20 compounds effective at concentrations < 25 μM were confirmed by fluorescence microscopy in several cell lines. Interestingly, kinetic analysis allowed the identification of inhibitors capable to interfere with the export receptor CRM1-mediated nuclear export not only in an irreversible, but also in a reversible fashion. In sum, exploitation of biosensor based screening allows the identification of chemicogenomic tools applicable for dissecting nucleo-cytoplasmic transport in living cells.Keywords
This publication has 41 references indexed in Scilit:
- A phosphorylation-acetylation switch regulates STAT1 signalingGenes & Development, 2009
- Dynamic Proteomics of Individual Cancer Cells in Response to a DrugScience, 2008
- A Robotic Platform for Quantitative High-Throughput ScreeningASSAY and Drug Development Technologies, 2008
- Structure, dynamics and function of nuclear pore complexesTrends in Cell Biology, 2008
- Targeting of the N‐terminal coiled coil oligomerization interface by a helix‐2 peptide inhibits unmutated and imatinib‐resistant BCR/ABLInternational Journal of Cancer, 2008
- The Survivin–Crm1 interaction is essential for chromosomal passenger complex localization and functionEMBO Reports, 2006
- Chemical Genomics: Dialed in Transcriptional Network Control with Non-steroidal Glucocorticoid Receptor ModulatorsACS Chemical Biology, 2006
- Mechanisms of Receptor‐Mediated Nuclear Import and Nuclear ExportTraffic, 2005
- Ratjadone and leptomycin B block CRM1‐dependent nuclear export by identical mechanismsFEBS Letters, 2004
- Nuclear transport and cancer: from mechanism to interventionNature Reviews Cancer, 2004